Primary Menu

Education, Events, Publication

Funding & Recognition

Maximizing Impact: Addressing Skin Penetration Challenges of Antiseptic Products for Infection Prevention

Semester: Spring 2024

Presentation description

Every year, 0.8-2 million patients contract a surgical site infection (SSI), increasing patient mortality 2-11 fold. SSIs are caused by an individual's own skin bacteria. Hospitals use chlorohexidine gluconate (CHG) products, like CHG IV port and wound dressings that release CHG into the skin via diffusion. We hypothesized that the quantity of CHG released from antimicrobial products would determine the product's effectiveness in reducing skin bacteria. We tested our hypothesis using a pig model

Presenter Name: Porter Stulce

Presentation Type: Poster
Presentation Format: In Person
Presentation #A1
College: Engineering
School / Department: Bioengineering
Research Mentor: Dustin Williams
Date | Time: Tuesday, Apr 9th | 9:00 AM